Literature DB >> 19730020

Neurosarcoidosis presenting as Guillain-Barré-like syndrome. A case report and review of the literature.

Firas Fahoum1, Vivian E Drory, Josephine Issakov, Miri Y Neufeld.   

Abstract

Sarcoidosis is a multisystem inflammatory disease that can affect the nervous system. Cranial neuropathies are the most frequent presentation of neurosarcoidosis. Involvement of the peripheral nervous system is less common. The presentation is usually subacute or chronic sensorimotor axonal polyneuropathy, whereas acute polyradiculopathy is extremely rare. We report a case of Guillain-Barré-like syndrome probably secondary to sarcoidosis. A review of the literature revealed 9 similar cases. The possibility of a Guillain-Barré-like syndrome as a presenting symptom of sarcoidosis should be considered, especially in patients with atypical features such as cerebrospinal fluid pleocytosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19730020     DOI: 10.1097/CND.0b013e3181ae3be9

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  5 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  A rare manifestation of cricopharyngeal myopathy presenting with dysphagia in sarcoidosis.

Authors:  Kaori Nishikubo; Masamitsu Hyodo; Miyuki Kawakami; Taisuke Kobayashi
Journal:  Rheumatol Int       Date:  2011-11-25       Impact factor: 2.631

3.  Neurosarcoidosis: clinical review of a disorder with challenging inpatient presentations and diagnostic considerations.

Authors:  J Chad Hoyle; Courtney Jablonski; Herbert B Newton
Journal:  Neurohospitalist       Date:  2014-04

4.  An Atypical and Multifactorial Acute Immune Polyradiculopathy: A Case Report.

Authors:  Matthew R Brier; Elyse A Everett; Robert C Bucelli
Journal:  Neurohospitalist       Date:  2019-07-24

5.  Neurosarcoidosis.

Authors:  David Lacomis
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.